William DeMaio

710 total citations
20 papers, 493 citations indexed

About

William DeMaio is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, William DeMaio has authored 20 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Pharmacology and 5 papers in Pharmacology. Recurrent topics in William DeMaio's work include Pharmacogenetics and Drug Metabolism (4 papers), Estrogen and related hormone effects (4 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). William DeMaio is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Estrogen and related hormone effects (4 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). William DeMaio collaborates with scholars based in United States, Canada and United Kingdom. William DeMaio's co-authors include Rasmy Talaat, John C. L. Erve, JoAnn Scatina, Yongdong Wang, M. F. Gu, Appavu Chandrasekaran, Matthew Hoffmann, Dawn Harper, John Speth and Sarvesh C. Vashishtha and has published in prestigious journals such as PLoS ONE, Clinical Pharmacology & Therapeutics and Drug Metabolism and Disposition.

In The Last Decade

William DeMaio

20 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William DeMaio United States 12 198 135 89 81 65 20 493
Hideyo Noguchi Japan 17 190 1.0× 143 1.1× 165 1.9× 128 1.6× 28 0.4× 55 774
Xialin Luo China 9 328 1.7× 54 0.4× 74 0.8× 78 1.0× 45 0.7× 9 548
Timo Mauriala Finland 19 352 1.8× 294 2.2× 53 0.6× 66 0.8× 22 0.3× 22 896
Sherry Wang United States 10 298 1.5× 216 1.6× 63 0.7× 26 0.3× 76 1.2× 15 807
Mohd Yaseen Malik India 11 160 0.8× 28 0.2× 46 0.5× 66 0.8× 14 0.2× 17 416
Haitang Xie China 14 332 1.7× 24 0.2× 87 1.0× 119 1.5× 25 0.4× 43 583
James Atherton United States 10 115 0.6× 24 0.2× 70 0.8× 135 1.7× 14 0.2× 11 405
Evan B. Smith United States 12 139 0.7× 53 0.4× 68 0.8× 120 1.5× 7 0.1× 13 379
Yoshiro Kohno Japan 11 98 0.5× 32 0.2× 91 1.0× 103 1.3× 12 0.2× 36 365
Gwyn A. Lord United Kingdom 14 238 1.2× 178 1.3× 41 0.5× 58 0.7× 63 1.0× 33 708

Countries citing papers authored by William DeMaio

Since Specialization
Citations

This map shows the geographic impact of William DeMaio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William DeMaio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William DeMaio more than expected).

Fields of papers citing papers by William DeMaio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William DeMaio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William DeMaio. The network helps show where William DeMaio may publish in the future.

Co-authorship network of co-authors of William DeMaio

This figure shows the co-authorship network connecting the top 25 collaborators of William DeMaio. A scholar is included among the top collaborators of William DeMaio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William DeMaio. William DeMaio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Borghoff, Susan J., et al.. (2019). Nondetectable or minimal detectable residue levels of N-(n-butyl) thiophosphoric triamide in bovine tissues and milk from a 28-d NBPT dosing study. Translational Animal Science. 3(4). 1606–1616. 6 indexed citations
2.
3.
DeMaio, William, et al.. (2011). Metabolism Studies of Desvenlafaxine. Journal of Bioequivalence & Bioavailability. 3(7). 24 indexed citations
4.
Tong, Zeen, Appavu Chandrasekaran, William DeMaio, et al.. (2010). Metabolism of Vabicaserin in Mice, Rats, Dogs, Monkeys, and Humans. Drug Metabolism and Disposition. 38(12). 2266–2277. 6 indexed citations
5.
Chandrasekaran, Appavu, et al.. (2010). Disposition of bazedoxifene in rats. Xenobiotica. 40(8). 578–585. 6 indexed citations
6.
Chandrasekaran, Appavu, Zeen Tong, Hongshan Li, et al.. (2010). Metabolism of Intravenous Methylnaltrexone in Mice, Rats, Dogs, and Humans. Drug Metabolism and Disposition. 38(4). 606–616. 24 indexed citations
7.
Shen, Li, William DeMaio, Aram Oganesian, et al.. (2010). In Vitro Metabolism, Permeability, and Efflux of Bazedoxifene in Humans. Drug Metabolism and Disposition. 38(9). 1471–1479. 19 indexed citations
8.
Tong, Zeen, Appavu Chandrasekaran, Hongshan Li, et al.. (2010). In Vitro Metabolism and Identification of Human Enzymes Involved in the Metabolism of Methylnaltrexone. Drug Metabolism and Disposition. 38(5). 801–807. 20 indexed citations
9.
Tong, Zeen, et al.. (2009). Species Differences in the Formation of Vabicaserin Carbamoyl Glucuronide. Drug Metabolism and Disposition. 38(4). 581–590. 11 indexed citations
10.
Chandrasekaran, Appavu, et al.. (2009). Metabolic Disposition of [14C]Bazedoxifene in Healthy Postmenopausal Women. Drug Metabolism and Disposition. 37(6). 1219–1225. 35 indexed citations
11.
Erve, John C. L., M. F. Gu, Yongdong Wang, William DeMaio, & Rasmy Talaat. (2009). Spectral accuracy of molecular ions in an LTQ/Orbitrap mass spectrometer and implications for elemental composition determination. Journal of the American Society for Mass Spectrometry. 20(11). 2058–2069. 110 indexed citations
12.
Boni, Joseph, Richat Abbas, Cathie Leister, et al.. (2008). Disposition of desipramine, a sensitive cytochrome P450 2D6 substrate, when coadministered with intravenous temsirolimus. Cancer Chemotherapy and Pharmacology. 64(2). 263–270. 11 indexed citations
13.
Erve, John C. L., William DeMaio, & Rasmy Talaat. (2008). Rapid metabolite identification with sub parts‐per‐million mass accuracy from biological matrices by direct infusion nanoelectrospray ionization after clean‐up on a ZipTip and LTQ/Orbitrap mass spectrometry. Rapid Communications in Mass Spectrometry. 22(19). 3015–3026. 51 indexed citations
14.
15.
Erve, John C. L., Sarvesh C. Vashishtha, William DeMaio, & Rasmy Talaat. (2007). Metabolism of Prazosin in Rat, Dog, and Human Liver Microsomes and Cryopreserved Rat and Human Hepatocytes and Characterization of Metabolites by Liquid Chromatography/Tandem Mass Spectrometry. Drug Metabolism and Disposition. 35(6). 908–916. 29 indexed citations
16.
Trybulski, Eugene J., et al.. (2007). Identification and synthesis of major metabolites of Vasopressin V2-receptor agonist WAY-151932, and antagonist, Lixivaptan®. Bioorganic & Medicinal Chemistry Letters. 17(21). 5796–5800. 10 indexed citations
17.
Hoffmann, Matthew, William DeMaio, Rasmy Talaat, et al.. (2007). Metabolism, Excretion, and Pharmacokinetics of [14C]Tigecycline, a First-In-Class Glycylcycline Antibiotic, after Intravenous Infusion to Healthy Male Subjects. Drug Metabolism and Disposition. 35(9). 1543–1553. 76 indexed citations
18.
Wang, Jianyao, William DeMaio, Appavu Chandrasekaran, et al.. (2006). Mechanism Study of N-Dephenylation Mediated through a N-para-Hydroxy Metabolite. Current Drug Discovery Technologies. 3(2). 101–114. 4 indexed citations
19.
Keating, Kelly A., Oliver J. McConnell, Yingru Zhang, et al.. (2006). NMR CHARACTERIZATION OF AN S-LINKED GLUCURONIDE METABOLITE OF THE POTENT, NOVEL, NONSTEROIDAL PROGESTERONE AGONIST TANAPROGET. Drug Metabolism and Disposition. 34(8). 1283–1287. 8 indexed citations
20.
Ermer, James, H. Lee, William DeMaio, et al.. (2003). Bazedoxifene Acetate Metabolic Disposition in Healthy, Postmenopausal Women. Clinical Pharmacology & Therapeutics. 73(2). 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hideyo Noguchi Breakdown of academic impact, for papers by Xialin Luo Breakdown of academic impact, for papers by Timo Mauriala Breakdown of academic impact, for papers by Sherry Wang Breakdown of academic impact, for papers by Mohd Yaseen Malik Breakdown of academic impact, for papers by Haitang Xie Breakdown of academic impact, for papers by James Atherton Breakdown of academic impact, for papers by Evan B. Smith Breakdown of academic impact, for papers by Yoshiro Kohno Breakdown of academic impact, for papers by Gwyn A. Lord
Rankless by CCL
2026